Patent · US Active

Immunoassay for compounds of the NBOMe family

US9720005B2 · kind B2 · utility

7Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2015
Grant dateAug 1, 2017
Priority date
Expiry dateMay 28, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2430/00
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An immunoassay method for detecting and determining ‘NBOMe’ family designer drugs is described. Also described are components for use in implementing the method, namely, antibodies, detection agents, solid state devices and kits as well as immunogens used to raise the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.